ThinkGenetic

ThinkGenetic is a company dedicated to reducing the time to diagnosis for genetic and rare conditions by leveraging artificial intelligence and clinical expertise. The company offers two main solutions: FindEHR™ and FindSM™. FindEHR™ applies validated rare disease algorithms to millions of Electronic Health Records (EHRs) to uncover at-risk or diagnosed individuals, while FindSM™ is an interactive patient risk-assessment module that integrates into websites to provide insights on undiagnosed consumers concerned about their risk level. ThinkGenetic serves clients in biopharma, research institutions, healthcare practice settings, and advocacy organizations, providing sensitive and specific data that is HIPAA-compliant. The company’s solutions are designed to support healthcare providers and patients in identifying and managing rare genetic conditions. ThinkGenetic has been recognized with awards, including being voted best in the world by MIT and Horizon, and its FindEHR™ solution was a co-winner of the Horizon Prize, powered by MIT Solve. Additionally, ThinkGenetic collaborates with Guardian Research Network to accelerate diagnosis and treatment options for patients with genetic diseases and inherited predisposition to cancer. The company’s algorithms have sensitivity rates of 77 – 100% for identifying at-risk individuals, and its FindSM™ tool provides a chat-like experience for users to assess their risk and offers educational summaries to share with healthcare providers.